Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Reza Naghavian
Observed name:
R Naghavian
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
Royan Institute,
University of Zurich,
Academic Center for Education, Culture and Research,
University of Isfahan,
University Hospital Zurich
ORCID:
0000-0002-1328-4095
Observed ORCID:
0000-0002-1328-4095
OpenAlex ID:
A5064876371
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
2020
·
Jian Wang
, Ivan Jelcic
, et al.
·
Cell
·
292
PDF
Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
2023
·
Reza Naghavian
, Wolfgang Faigle
, et al.
·
Nature
·
174
PDF
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15
2020
·
Hana Zdimerova
, Anita Murer
, et al.
·
European Journal of Immunology
·
126
miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis
2015
·
Reza Naghavian
, Kamran Ghaedi
, et al.
·
PLoS ONE
·
95
PDF
Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases
2024
·
Carina Saggau
, Petra Bacher
, et al.
·
Immunity
·
89
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing–remitting multiple sclerosis
2015
·
Maryam Ahmadian-Elmi
, Ali Bidmeshki Pour
, et al.
·
Immunogenetics
·
57
T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis
2025
·
Ivan Jelcic
, Reza Naghavian
, et al.
·
Cell Reports Medicine
·
54
Integrative computational mRNA–miRNA interaction analyses of the autoimmune-deregulated miRNAs and well-known Th17 differentiation regulators: An attempt to discover new potential miRNAs involved in Th17 differentiation
2015
·
Mohammad Amin Honardoost
, Reza Naghavian
, et al.
·
Gene
·
50
Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis
2022
·
Josefine Ruder
, María José Docampo
, et al.
·
Science Translational Medicine
·
27
Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2022
·
Jian Wang
, Tobias Weiss
, et al.
·
Clinical Cancer Research
·
14
PDF
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells
2026
·
Andreas Lutterotti
, Thomas Ludersdorfer
, et al.
·
Proceedings of the National Academy of Sciences
·
1
Author response for "Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15"
2020
·
Hana Zdimerova
, Anita Murer
, et al.
·
Publons reviews and discussion
·
1
Figure S7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S8 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S5 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S1 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S3 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S6 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Supplementary Tables 1, 3, 5-7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
PDF
Table S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Table S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2025
·
Jian Wang
, Tobias Weiss
, et al.
Figure S7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2023
·
Jian Wang
, Tobias Weiss
, et al.
Table S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma
2023
·
Jian Wang
, Tobias Weiss
, et al.
Show more works
View as search
Works count:
45
Citation count:
980
H-index:
10
I10-index:
10
Year
Topic
Type